PreveCeutical Medical Inc. (CSE:PREV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
+0.0050 (20.00%)
At close: Dec 5, 2025

PreveCeutical Medical Company Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

The company is headquartered in West Vancouver, Canada.

PreveCeutical Medical Inc.
PreveCeutical Medical logo
Country Canada
Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer

Contact Details

Address:
5428 Marine Drive
West Vancouver, British Columbia V7W 2R2
Canada
Phone 604 416 7777
Website preveceutical.com

Stock Details

Ticker Symbol PREV
Exchange Canadian Securities Exchange
Fiscal Year January - December
Reporting Currency CAD
ISIN Number CA74141E1043
SIC Code 2834

Key Executives

Name Position
Stephen Van Deventer Chairman, Chief Executive Officer and Chief Financial Officer
Dr. Makarand Jawadekar Ph.D. Chief Science Officer, President and Director
Dr. Harendra Parekh BSc., Hons I, MRPharmS, Ph.D. Chief Research Officer
Dr. Francis Tavares Chief Technology Officer